Клинические испытания (активные) в Мьянма

In 2026, Myanmar hosted 10 шт. active clinical trials — a modest yet notable figure for a country gradually integrating into the global research landscape. Most studies are initiated through international partnerships and focus on tropical diseases like malaria and tuberculosis. This places Myanmar at 25 out of 197, highlighting both persistent challenges — weak regulatory frameworks and a shortage of skilled personnel — and a growing interest from pharmaceutical companies in studying local populations.